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Abstract: New Psychoactive Substances (NPS) belong to several chemical classes, including 
phenethylamines, piperazines, synthetic cathinones and synthetic cannabinoids. Development and 
validation of analytical methods for the determination of NPS both in traditional and alternative 
matrices is of crucial importance to study drug metabolism and to associate consumption to clinical 
outcomes and eventual intoxication symptoms. Among different biological matrices, hair is the one 
with the widest time window to investigate drug-related history and demonstrate past intake. 
The aim of this paper was to overview the trends of the rapidly evolving analytical methods for the 
determination of NPS in hair and the usefulness of these methods when applied to real cases. 
A number of rapid and sensitive methods for the determination of NPS in hair matrix has been 
recently published, most of them using liquid chromatography coupled to mass spectrometry. Hair 
digestion and subsequent solid phase extraction or liquid-liquid extraction were described as well as 
extraction in organic solvents. For most of the methods limits of quantification at picogram per 
milligram hair were obtained. The measured concentrations for most of the NPS in real samples were in 
the range of picograms of drug per milligram of hair. Interpretation of the results and lack of cut-off 
values for the discrimination between chronic consumption and occasional use or external 
contamination are still challenging. 
Methods for the determination of NPS in hair are continually emerging to include as many NPS as 
possible due to the great demand for their detection. 
Keywords: New psychoactive substances, hair, analytical methods, phenethylamines, piperazines, synthetic cathinones, 
synthetic cannabinoids. 
1. INTRODUCTION 
 In the recent years, an increasing global concern has been 
arisen over the rapid emergence of new substances in the 
market of illicit psychotropic drugs. New Psychoactive 
Substances (NPS) belong to several chemical classes, 
including but not limited to phenethylamines, piperazines, 
cathinones and synthetic cannabinoids. NPS have been 
synthesized to evade existing drug laws, usually by altering 
the chemical structures of illegal drugs or by finding drugs 
with different structures that produce effects similar to those 
of existing stimulant, hallucinogenic - psychedelic, sedative, 
dissociative or euphoric drugs. Furthermore, the use of new 
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psychoactive substances (NPS) as adulterants of stimulant 
recreational controlled drugs, has recently been documented 
as a new worrying phenomenon [1]. 
 Despite the increasing number of NPS and the fact that 
fatal and acute intoxication cases have been already attributed 
to this novel class of compounds [2, 3] this phenomenon 
appears to be considerably underestimated, mainly due to the 
substantial lack of comprehensive screening methods for the 
detection of NPS in biological samples. 
 The constant addition of new entries to the family of 
NPS, together with the wide physico-chemical variety of the 
single substances of this category makes their determination 
in biological specimens a demanding challenge in forensic 
and clinical toxicology [4]. Development of analytical 
methods for the determination of the latter substances both in 
conventional and non-conventional matrices is of great 
importance to investigate drug metabolism and to associate 
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intake to clinical outcomes and eventual intoxication 
symptoms. 
 Determination of these drugs and their metabolites in 
biological fluids or matrices other than blood or urine may be 
of interest in certain areas of drug concentration monitoring 
[5], since blood and urine drug testing may fail to document 
drug use when samples are collected at inconvenient times. 
Oral fluid is the only fluid which can be used successfully as 
a substitute for blood in therapeutic drug monitoring [6], 
while an individual's past history, can be obtained from drug 
analysis of the hair or nails. Drug concentrations in the bile 
and faeces can account for excretion of drugs and metabolites 
other than by the renal route. Furthermore, it is important 
that certain matrices (tears, nails, cerebrospinal fluid, bronchial 
secretions, peritoneal fluid and interstitial fluid) are analysed, 
as these may reveal the presence of a drug at the site of 
action; others (fetal blood, amniotic fluid and breast milk) 
are useful for determining fetal and perinatal exposure to 
drugs. 
 For all these reasons, drug concentration measurement in 
nonconventional matrices and fluids, although sometimes 
expensive and difficult to carry out, should therefore be 
considered for inclusion in studies of the pharmacokinetics 
and pharmacodynamics of new drugs [5]. 
 Hair analysis appears to be one of the most efficient tools 
to investigate drug-related history [7], due to the greater 
window of detection compared to that of blood and urine. 
Hair has been recently characterized as a peculiar tissue 
which ‘‘keeps memory’’ of the past history of drug intake of 
the subject [8]. 
 Hair drug testing has gained increased interest and 
recognition over the past two decades and its application has 
been recently expanded in both forensic and clinical 
toxicology. 
 Hair is recognized as a complimentary testing matrix and is 
widely used with samples routinely collected during criminal 
investigations. Hair testing has been successfully applied for 
consumption history of classical drugs of abuse and it is used 
to monitor drug usage during drug rehabilitation programmes 
[9] in post- mortem cases [10] in workplace drug testing  
[11] driving license regranting [12] and in child custody 
cases [13, 14]. Moreover, hair testing has been proposed to 
complement and/or substitute traditional doping control 
strategies and corresponding test matrices [15, 16]. In the 
light of that, similarly to what happened with traditional drugs 
of abuse, assays for the determination of NPS and eventual 
metabolites in hair are in continuous development due to the 
high demand for the detection of the latter substances both in 
clinical and forensic cases. 
 Although NPS have been determined in various alternative 
matrices including stomach content [17], vitreous humour 
[18], meconium [19], brain, heart, lung, liver, kidney, spleen, 
and pancreas [20-22], the vast majority of the literature 
focuses on two alternative matrices: hair and oral fluid. In this 
concern, recently Øiestad et al. published a comprehensive 
review on the trends in analytical methods for the detection 
and/or quantification of NPS in oral fluid [23]. 
 In this paper we present the trends of the rapidly evolving 
analytical methods for the determination of NPS in hair. This 
review includes methods for hair testing of NPS using 
chromatographic assays up to March 2016; some describing 
simultaneous detection of a number of NPS from different 
chemical classes [24-29] in hair and others focusing on the 
determination of just one class [7, 19, 30-40]. Moreover, the 
usefulness of these methods when applied to real cases has 
also been discussed. An exhaustive Table (Table 1) shows 
the overview of analytical methods for determination of NPS 
in hair, sorted by chemical class, reporting the most possible 
details concerning sample treatment, type of analytes 
separation, detection mode and validation parameters. 
2. ANALYTICAL METHODS FOR THE DETER- 
MINATION OF NPS IN HAIR 
2.1. Analytical Methods for the Determination of 
Phenethylamines in Hair 
 Phenethylamines are a broad family of chemical variants of 
the core compounds, i.e., amphetamine, methamphetamine 
and MDMA [41]. 2 C-x is a general name of substituted 
phenethylamines which contain methoxy groups on the 2 and 
5 positions of the benzene ring of phenethylamine and a 
variety of lipophilic substituents at position 4. The substances 
of this category show a prevalent hallucinogenic and 
psychedelic effect. The N-benzyl substituted phenethylamines 
(NBOMEs) are highly potent hallucinogens even in doses of 
micrograms, as the N-benzyl substitution of phenethylamines 
dramatically increases their affinity with the serotonin 2A (5-
HT2A) receptors [42]. 
2.1.1. 2 C-x Series 
 Two studies have been carried out for the determination 
of NPS belonging to the 2 C-x series in hair. Montenarh et 
al. developed a liquid chromatography tandem mass 
spectrometry (LC-MS/MS) screening method for the 
detection of the following substances: 2 C-P, 2 C-B, 2 C-D, 
2 C-E, 2 C-I and 2 C-T, among other compounds of different 
chemical classes [29]. An amount of 20 mg washed and 
pulverized hair were extracted with diethyl ether-ethyl 
acetate mixture (1:1). 
 The analysis was carried out using LC-QTRAP operated in 
the positive electrospray ionization (ESI+) mode. Separation 
was achieved with gradient elution on a C18 column (2.1 × 
150 mm, 3.5 µm) and the mobile phase consisted of 10 mM 
aqueous ammonium formate plus 0.1% formic acid pH 3.4 
(eluent A) and acetonitrile plus 0.1% formic acid (eluent B). 
 Recovery and intraday precision was given only for the 2 
C-P, with precision falling out of the acceptable criteria for 
the high control samples (63.7%) whereas LODs provided 
for all the above mentioned substances, ranged from 0.02 to 
0.1 ng/mg. The new approach was tested for applicability by 
analyzing among others 13 hair samples, however no results 
on the eventual presence of 2 C-x compounds were provided. 
 Salomone et al. developed an ultra high performance 
liquid chromatography tandem mass spectrometry (UHPLC–
MS/MS) assay for the determination of 31 stimulant and 
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Table 1. Overview of confirmation methods for determination of NPS in hair. Sorted by chemical class. 
Substance Method Assay Extraction 
Method 
Absolute 
Recovery 
(%) 
Intraday 
Precision 
(RSD) 
Interday 
Precision 
(RSD) 
Intraday 
Accuracy 
(% Error) 
Interday 
Accuracy 
(% Error) 
LOD 
(pg/mg) 
LOQ 
(pg/mg) 
Refs. 
Phenethylamines 
2 C-x series 
LC-MS/MS LLE 72-130 12.4-63.7    50  [29] 2 C-P 
UHPLC-MS/MS MeOH 96     1 2 [27] 
LC-MS/MS LLE      80  [29] 2 C-B 
UHPLC-MS/MS MeOH 97     6.2 12 [27] 
2 C-D LC-MS/MS LLE      50  [29] 
2 C-E LC-MS/MS LLE      20  [29] 
2 C-I LC-MS/MS LLE      80  [29] 
2 C-T LC-MS/MS LLE      100  [29] 
25H-NBOMe UHPLC-MS/MS MeOH 102     1 2 [27] 
25C-NBOMe UHPLC-MS/MS MeOH 100     1.5 3 [27] 
25B-NBOMe UHPLC-MS/MS MeOH 102     4.1 8.2 [27] 
25I-NBOMe UHPLC-MS/MS MeOH 97     1.5 3 [27] 
Other phenethylamines 
LC-MS/MS SPE      10 50 [25] PMA 
UHPLC-MS/MS MeOH 98     8.8 18 [27] 
PMMA UHPLC-MS/MS MeOH 97     1.3 2.6 [27] 
4-MA LC-MS/MS Formic 
Acid 
 2-10 1-11   5 10 [24] 
LC-MS/MS SPE      20 50 [25] 4-MTA 
LC-MS/MS Formic 
Acid 
 4-11 1-12   2 20 [24] 
4-FA LC-MS/MS Formic 
Acid 
 3-15 1-15   2 5 [24] 
UHPLC-MS/MS MeOH 94     1.6 3.2 [27]  
LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
5-MAPB UHPLC-MS/MS MeOH 100     4.6 9.2 [27] 
6-APB UHPLC-MS/MS MeOH 94     17 35 [27] 
4-FMA LC-MS/MS MSPE 68.6 - 82 4.4-6.2 3-6.8 101.9-
104.6a 
 2 10 [26] 
LC-MS/MS Formic 
Acid 
 2-12 2-12   5 20 [24] Butylone 
UHPLC-MS/MS MeOH 97     3.7 7.4 [27] 
 LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
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(Table 1) Contd…. 
Substance Method Assay Extraction 
Method 
Absolute 
Recovery 
(%) 
Intraday 
Precision 
(RSD) 
Interday 
Precision 
(RSD) 
Intraday 
Accuracy 
(% Error) 
Interday 
Accuracy 
(% Error) 
LOD 
(pg/mg) 
LOQ 
(pg/mg) 
Refs. 
Piperazines 
LC-MS/MS SPE      10 50 [25] 
LC-MS/MS Formic 
Acid 
 0.2-12 3-12   5 20 [24] 
GC-MS MSPE 92.7 - 100 7.70-
16.17 
2.01-9.64 -0.80-
13.21 
-5.03-6.36  50 [33] 
LC-MS/MS MSPE 70.3 - 79.7 2.3-4 1.8-2.6 96.9-
102.9a 
 5 10 [26] 
UHPLC-MS/MS MeOH 91     3 6 [27] 
mCPP 
LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
LC-MS/MS Formic 
Acid 
 0.4-11 3-11   5 20 [24] Benzylpiperaz
ine 
LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
GC-MS MSPE 91.3 - 
101.3 
4.70-
12.12 
2.15-6.55 -8.45-
10.07 
-4.57-4.30  50 [33] 
LC-MS/MS MSPE 61.5-68.9 1.8-3.3 1.5-3 99.8-
103.7a 
 1 10 [26] 
TFMPP 
LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
MeOPP GC-MS MSPE 92-101.3 4.46-
12.77 
1.72-13.7 -8.45-
18.53 
-10.18-
17.23 
 50 [33] 
Cathinones 
UHPLC-MS/MS MeOH 91     2 4 [27] α-PVP 
LC-MS Extrelut 
column 
 Within 
9.4b 
Within 
9.4b 
  0.02 
ng/10-
mm 
0.05 
ng/10-
mm 
[35] 
α-PBP LC-MS Extrelut 
column 
 Within 
9.4b 
Within 
9.4b 
  0.02 
ng/10-
mm 
0.05 
ng/10-
mm 
[35] 
Buphedrone UHPLC-MS/MS MeOH 79     4.2 8.4 [27] 
Amfepramone UHPLC-MS/MS MeOH 81     4 8 [27] 
3,4-DMMC LC-MS/MS Formic 
Acid 
 3-12 8-15   5 20 [24] 
LC-MS/MS Formic 
Acid 
 1-4 3-13   5 20 [24] 4-MEC 
UHPLC-MS/MS MeOH 86     3 6 [27] 
3-MMC LC-HRMS methanol:tri
fluoroacetic 
acid 9:1 
 Within 
0.8 
Within 
6.9 
  20 100 [7] 
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Substance Method Assay Extraction 
Method 
Absolute 
Recovery 
(%) 
Intraday 
Precision 
(RSD) 
Interday 
Precision 
(RSD) 
Intraday 
Accuracy 
(% Error) 
Interday 
Accuracy 
(% Error) 
LOD 
(pg/mg) 
LOQ 
(pg/mg) 
Refs. 
Cathinones 
LC-MS/MS Formic 
Acid 
 1-12 1-5   20 20 [24] Ethcathinone 
UHPLC-MS/MS MeOH 88     3.1 6.2 [27] 
LC-MS/MS Formic 
Acid 
 4-14 1-14   2 5 [24] Ethylone 
LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
LC-MS/MS Formic 
Acid 
 1-6 1-9   2 20 [24] 
LC-MS/MS MSPE 51.1- 59.8 2.2 - 3 0.3 - 6.2 99-109.3a  1 2 [26] 
Mephedrone 
 
UHPLC-MS/MS MeOH 81     2.4 4.8 [27] 
GC-MS HCl (0.01 
M): MeOH 
>76 3.5 - 3.9 9.5 - 12.9 91.8 - 94.2 88 - 94.8 80 200 [45] 
LC-MS/MS LLE 90.4- 
110.4 
0.4 - 2.6 0.7 - 4.5 99.15-
107.53c 
 2.5 5 [30] 
 
LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
4-Methyle- 
phedrine 
LC-MS/MS LLE 98.4-106.2 0.6-4.92 0.7-4 98.52-
114.59c 
 5 10 [30] 
4-Methylnore- 
phedrine 
LC-MS/MS LLE 96.8-101.3 0.2-6.97 0.7-7.3 97.6-
107.98c 
 5 10 [30] 
LC-MS/MS Formic 
Acid 
 1 - 13 1 - 12   2 20 [24] Methedrone 
LC-MS/MS MSPE 67.6- 72.4 3.3 - 5.6 2 - 7 103.9-
106.2a 
 1 2 [26] 
Methcathinone LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
LC-MS/MS Formic 
Acid 
 2 - 12 1 - 6   2 20 [24] 
UHPLC-MS/MS MeOH 85     3.2 6.4 [27] 
LC-MS/MS MSPE 70.8 - 74.4 2.2 - 2.8 2.8 - 4.7 102.2-
109.3a 
 1 2 [26] 
Methylone 
 
LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
Naphyrone LC-MS/MS Formic 
Acid 
 2 - 17 4 - 14   10 20 [24] 
Pentedrone LC-MS/MS Formic 
Acid 
 3 - 16 1 - 15   2 20 [24] 
 UHPLC-MS/MS MeOH 87     3.9 7.8 [27] 
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Substance Method Assay Extraction 
Method 
Absolute 
Recovery 
(%) 
Intraday 
Precision 
(RSD) 
Interday 
Precision 
(RSD) 
Intraday 
Accuracy 
(% Error) 
Interday 
Accuracy 
(% Error) 
LOD 
(pg/mg) 
LOQ 
(pg/mg) 
Refs. 
Cathinones 
Pentylone LC-MS/MS Formic Acid  2 - 16 3 - 10   2 20 [24] 
LC-MS/MS MSPE 47.8 - 53.9 3 - 4.9 7.4 - 11.2 97.7-104.5a  5 10 [26] 4-FMC 
LC-MS/MS Formic Acid  2-12 0.2-6   5 10 [24] 
LC-MS/MS MSPE 75.8-85.0 2.6-5.4 0-3.9 102-104.6a  0.2 2 [26] 
UHPLC-MS/MS MeOH 96     2 4 [27] 
LC-MS/MS MeOH and 
acidified 
MeOH 
     10  [28] 
LC-MS/MS Formic Acid  4-13 1-14   2 5 [24] 
MDPV 
LC-MS Extrelut 
column 
 9.4b 9.4b   0.02 ng/ 
10-mm 
0.05 ng/ 
10-mm 
[35] 
Cannabinoids 
Benzoylindoles 
AM2233 LC-MS/MS MeOH  2 - 3 2 - 8   10 20 [24] 
LC-MS/MS MeOH  0.3 - 3 2 - 11   10 20 [24] 
LC-MS/MS LLE      20  [29] 
UHPLC-MS/MS LLE 93     0.8 2.6 [32] 
LC-MS/MS Ethanol 84-96 3.1-7.8 4.1-7.8 -6.1-5.2c  0.5 0.5 [34] 
AM694 
LC-QTOF MS LLE       20 [8] 
LC-MS/MS LLE      100  [29] RCS-4 
UHPLC-MS/MS LLE 99     0.7 2.3 [32] 
LC-MS/MS MeOH  1 - 10 2 - 12   10 20 [24]  
LC-MS/MS Ethanol 81-97 3.1-6.3 4.5-8.7 -0.3-5.2c  0.5 0.5 [34] 
RCS-4 ortho 
isomer 
LC-MS/MS Ethanol 83-98 2.6-7.1 2.6-6.8 -3.8-2.7c  0.5 0.5 [34] 
UHPLC-MS/MS LLE 91     0.7 2.3 [32] 
LC-MS/MS MeOH  1 - 5 2 - 6   5 20 [24] 
WIN 48.098 
LC-MS/MS Ethanol 87-95 1.8-7.8 4.7-9.9 -6.4-1.9c  0.5 0.5 [34] 
Naphthoylindoles 
AM-1220 UHPLC-MS/MS LLE 106     0.4 1.3 [32] 
LC-MS/MS MeOH      10 10 [24] 
LC-MS/MS LLE      20  [29] 
UHPLC-MS/MS LLE 88     0.7 2.3 [32] 
LC-MS/MS Ethanol 85-97 2.4-4.8 4.6-10.3 -3.1 -4.8c  0.5 0.5 [34] 
AM2201 
LC-MS/MS MeOH 74-93  0.3-4.8 -1.3-0.4c  0.05 0.1 [37] 
AM-2201  
N-4-OH M 
LC-MS/MS MeOH 95-107  2.5-3.2 -0.1-33c  0.05 0.1 [37] 
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Substance Method Assay Extraction 
Method 
Absolute 
Recovery 
(%) 
Intraday 
Precision 
(RSD) 
Interday 
Precision 
(RSD) 
Intraday 
Accuracy 
(% Error) 
Interday 
Accuracy 
(% Error) 
LOD 
(pg/mg) 
LOQ 
(pg/mg) 
Refs. 
Naphthoylindoles 
AM-2201 N-6-
OHindole M 
LC-MS/MS MeOH 93-128  1-1.9 0.9-2.4c  0.05 0.1 [37] 
LC-MS/MS MeOH  1 - 6 1 - 8   5 10 [24] 
UHPLC-MS/MS LLE 91     0.2 0.7 [32] 
JWH-007 
LC-MS/MS Ethanol 81-96 3-4.4 3.7-8.4 -6.9- -1.8c  0.5 0.5 [34] 
JWH-015 LC-MS/MS MeOH  1 - 3 1 - 9   2 10 [24] 
LC-MS/MS LLE      500  [29] 
UHPLC-MS/MS LLE 84     0.6 2 [32] 
 
LC-MS/MS Ethanol 83-97 3.8-5.6 3.8-6.7 -0.1-1.3c  0.5 0.5 [34] 
LC-MS/MS MeOH  2-8 2 - 10   5 10 [24] 
LC-MS/MS LLE      500  [29] 
UHPLC-MS/MS LLE 102     0.9 3 [32] 
LC-MS/MS Ethanol 83-97 1.8-6.7 4.1-8.2 -3.8-3.5c  0.5 0.5 [34] 
UHPLC-MS-MS LLE  2.3-4.2 4.2-5.8 -3-0 -4.3- -1.1 0.18 0.59 [31] 
UHPLC-MS-MS MeOH 78-94  1-5.6 -1-7.3c  0.05 0.1 [36] 
JWH-018 
LC-QTOF MS LLE       10 [8] 
JWH-018  
N-4-OH M 
UHPLC-MS-MS MeOH 93-95  5.7-6.3 1.2-3.4c  0.05 0.1 [36] 
JWH-018  
N-5-OH M 
UHPLC-MS-MS MeOH 98-100  6.2-8.5 1.8-2.6c  0.05 0.1 [36] 
JWH-018  
N-COOH M 
UHPLC-MS-MS MeOH 97-101  4.2-10 0.2-0.5c  0.05 0.1 [36] 
LC-MS/MS MeOH  0.3 - 10 3 - 7   5 20 [24] 
UHPLC-MS/MS LLE 114     1 3.3 [32] 
JWH-019 
LC-MS/MS Ethanol 82-98 4.5-5.3 5.3-6.5 -2.6-4.2c  0.5 0.5 [34] 
LC-MS/MS MeOH  1 - 4 3 - 11   10 20 [24] JWH-073 
LC-MS/MS LLE      500  [29] 
UHPLC-MS/MS LLE 100     0.5 1.6 [32] 
LC-MS/MS Ethanol 83-98 5.9-8.2 7.8-11.6 -4.6- 1.9c  0.5 0.5 [34] 
UHPLC-MS/MS MeOH 83-96  7.9-9.8 -1.5-3.6c  0.05 0.1 [36] 
UHPLC-MS-MS LLE  1.9-3.4 4.4-8.2 -5.2-8.6 -6.1- -1.4 0.1 0.33 [31] 
 
LC-QTOF MS LLE       10 [8] 
JWH-073  
N-3-OH M 
UHPLC-MS/MS MeOH 97-101  7-8.2 -3.5-2.6c  0.05 0.1 [36] 
JWH-073  
N-4-OH M 
UHPLC-MS/MS MeOH 94-98  6.6-10 -1.9- -1c  0.1 0.1 [36] 
JWH-073  
N-COOH M 
UHPLC-MS/MS MeOH 94-95  0.7-3.4 0.7-5.5c  0.05 0.1 [36] 
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Substance Method Assay Extraction 
Method 
Absolute 
Recovery 
(%) 
Intraday 
Precision 
(RSD) 
Interday 
Precision 
(RSD) 
Intraday 
Accuracy 
(% Error) 
Interday 
Accuracy 
(% Error) 
LOD 
(pg/mg) 
LOQ 
(pg/mg) 
Refs. 
Naphthoylindoles 
LC-MS/MS MeOH  1 - 7 1 - 10   5 20 [24] 
UHPLC-MS/MS LLE 95     0.6 2 [32] 
LC-MS/MS Ethanol 85-99 3.2-6.9 5.9-9.5 -4.5-4c  0.5 0.5 [34] 
JWH-081 
LC-QTOF MS LLE       10 [8] 
JWH-098 LC-MS/MS MeOH  1 - 11 2 - 11   5 20 [24] 
LC-MS/MS MeOH  2 - 9 2 - 11   10 20 [24] 
LC-MS/MS LLE      500  [29] 
UHPLC-MS/MS LLE 106     0.9 3 [32] 
LC-MS/MS Ethanol 82-97 2.8-7.1 5.3-7.1 -4.3-1.8c  0.5 0.5 [34] 
JWH-122 
LC-MS/MS MeOH 87-95  1.8-2.5 -0.6-3.3c  0.05 0.1 [37] 
 LC-QTOF MS LLE       20 [8] 
JWH-122  
N-5-OH 
LC-MS/MS MeOH 97-111  1.6-3.9 1.1-3.6c  0.05 0.1 [37] 
LC-MS/MS MeOH  1 - 7 6 - 13   5 10 [24] 
LC-MS/MS LLE      20  [29] 
UHPLC-MS-MS LLE  1.3-2.1 4.4-6.8 -4-6.1 -6.1-4.6 0.02 0.07 [31] 
UHPLC-MS/MS LLE 106     0.4 1.3 [32] 
LC-MS/MS Ethanol 86-95 1.6-5 4.7-8.1 -6.9- -0.5c  0.5 0.5 [34] 
JWH-200 
LC-QTOF MS LLE       10 [8] 
LC-MS/MS LLE 77 - 90 12.4 - 50.4    10  [29] 
UHPLC-MS/MS LLE 114     0.7 2.3 [32] 
LC-MS/MS Ethanol 95-97 3.7-8.9 8-9.5 -6.2- -0.1c  0.5 0.5 [34] 
JWH-210 
LC-QTOF MS LLE       10 [8] 
UHPLC-MS/MS LLE 110     0.8 2.6 [32] WIN 55.212-2 
LC-MS/MS Ethanol  6-8.2 6.3-9.9 -3.8-3.9c  0.5 0.5 [34] 
MAM-2201 LC-MS/MS MeOH 89-100  0.3-1.2 -0.2-1.9c  0.05 0.1 [37] 
MAM-2201  
N-COOH M 
LC-MS/MS MeOH 95-112  1.6-3.4 1.8-2.9c  0.05 0.1 [37] 
MAM-2201  
N-4-OH M 
LC-MS/MS MeOH 97-111  1-4.8 0.5-3.3c  0.05 0.1 [37] 
LC-MS/MS MeOH  1 - 5 1 - 10   5 10 [24] JWH-398 
UHPLC-MS/MS LLE 106     0.3 1 [32] 
 LC-MS/MS Ethanol 80-100 1.4-8.2 8.8-10.5 -4.5-1.1c  5 5 [34] 
Phenylacetylindoles 
LC-MS/MS LLE      50  [29] 
UHPLC-MS/MS LLE 91     0.7 2.3 [32] 
JWH-203 
LC-MS/MS Ethanol 83-99 2.8-4.3 3.6-8.1 -6.1-0.3c  0.5 0.5 [34] 
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(Table 1) Contd…. 
Substance Method 
Assay 
Extraction 
Method 
Absolute 
Recovery 
(%) 
Intraday 
Precision 
(RSD) 
Interday 
Precision 
(RSD) 
Intraday 
Accuracy 
(% Error) 
Interday 
Accuracy 
(% Error) 
LOD 
(pg/mg) 
LOQ 
(pg/mg) 
Refs. 
Phenylacetylindoles 
LC-MS/MS MeOH  1 - 8 2 - 12   10 20 [24] 
LC-MS/MS LLE      10  [29] 
UHPLC-
MS/MS 
LLE 98     0.5 1.6 [32] 
LC-MS/MS Ethanol 84-96 4.2-4.5 4.2-9.2 -3.2-6.1c  0.5 0.5 [34] 
UHPLC-
MS-MS 
LLE  2.3-2.4 2.7-7.2 -4.5-2 -5 - -4.8 0.04 0.13 [31] 
JWH-250 
LC-QTOF 
MS 
LLE       10 [8] 
LC-MS/MS MeOH  3 - 10 2 - 12   10 20 [24] 
UHPLC-
MS/MS 
LLE 86     0.3 1 [32] 
JWH-251 
LC-MS/MS Ethanol 81-98 1.2-6.6 3-10.9 -4.3- -0.5c  0.5 0.5 [34] 
JWH-302 LC-MS/MS MeOH  1 - 3 1 - 5    0 [24] 
RCS-8 LC-MS/MS MeOH  2 - 7 2 - 15   5 10 [24] 
UHPLC-
MS/MS 
LLE 108     0.9 3 [32]  
LC-MS/MS Ethanol 80-97 2.9-8.6 4.1-8.7 -4.4-3.1c  0.5 0.5 [34] 
Naphthoylpyrroles 
JWH-030 LC-MS/MS MeOH  1 - 4 1 - 10   10 10 [24] 
JWH-147 LC-MS/MS MeOH  1 - 2 1 - 13   10 20 [24] 
LC-MS/MS MeOH  1 - 9 1 - 9   10 20 [24] JWH-307 
UHPLC-
MS/MS 
LLE 113     1.3 4.3 [32] 
Other cannabinoids 
UHPLC-
MS/MS 
LLE 112     24 80 [32] HU-210 
UHPLC-
MS-MS 
LLE  2.3-3.1 5.8-7.9 2.6-13.6 0.9-13.8 3 9.9 [31] 
Methanandamide 
(AM-356) 
LC-MS/MS Ethanol 82-98 2.4-6.7 4.8-8.8 -6.3- -0.5c  5 5 [34] 
XLR-11 LC-MS/MS MeOH 84-103 3.1-7.9 8.3-11.7 -7.4-4.8 -6.6- -2.6 0.01 0.2 [38] 
UR-144 LC-MS/MS MeOH 94-105 6.1-6.2 8.6-9.8 -7- -4.9 -8.6- -5.2 0.01 0.2 [38] 
UR-144 N-4-OH M LC-MS/MS MeOH 66-98 4.5-7.5 6.6-9.5 -6.2- -3.5 -8.5- -7.6 0.01 0.2 [38] 
UR-144 N-5-OH M LC-MS/MS MeOH 58-64 10.1-11.1 7.1-9.8 -7.2- -5.9 -8- -5.6 0.01 0.2 [38] 
UR-144 N-COOH M LC-MS/MS MeOH 94-105 6.5-10.2 10.1-10.4 -10.3- -7.8 -9.4- -9.2 0.01 0.2 [38] 
XLR-11 N-4-OH M LC-MS/MS MeOH 87-103 5.5-7.6 6.4-9.3 -6.5- -1.9 -8.9- -3.4 0.2 0.2 [38] 
CB-13 LC-MS/MS MeOH  1 - 5 6 - 12   10 20 [24] 
JWH-016 LC-MS/MS MeOH  1 - 9 1 - 8   5 10 [24] 
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(Table 1) Contd…. 
Substance Method 
Assay 
Extraction 
Method 
Absolute 
Recovery 
(%) 
Intraday 
Precision 
(RSD) 
Interday 
Precision 
(RSD) 
Intraday 
Accuracy 
(% Error) 
Interday 
Accuracy 
(% Error) 
LOD 
(pg/mg) 
LOQ 
(pg/mg) 
Refs. 
Other cannabinoids 
UHPLC-
MS/MS 
LLE 101     0.2 0.7 [32] JWH-020 
LC-MS/MS Ethanol 79-99 4.5-11.1 8-11.1 -6.3- -0.8c  0.5 0.5 [34] 
JWH-201 LC-MS/MS MeOH  1 - 4 2 - 11   2 10 [24] 
AB-CHMINACA LC-MS/MS MeOH       2.5 [39] 
5F-PB-22 LC-MS/MS MeOH       1 [39] 
Other NPS 
MXE UHPLC-
MS/MS 
MeOH 98     1 2 [27] 
4-MeO-PCP UHPLC-
MS/MS 
MeOH 87     9 1.8 [27] 
Diphenidine UHPLC-
MS/MS 
MeOH 85     3.4 6.8 [27] 
a: % target concentration 
b: The method was linear from LOQ to 50 ng/10-mm hair segment, with maximum values for intraday and interday precisions in hair, tested at 0.4, 4, and 40 ng/10-mm hair segment 
being 9.4 %. LOD and LOQ values of 0.02 and 0.05 ng/10-mm, respectively were achieved. 
c: not defined as intra- or inter-day accuracy. 
 
psychedelic substituted phenethylamines and dissociative 
drugs in hair matrix [27]. Of the 2 C-x series 2 C-P, 2 C-B 
and 4 substances of the NBOMe group were tested. The 
method employed simple sample pre-treatment: extraction of 
25 mg washed and cut hair sample in MeOH at 55 °C for 15 h. 
 All analyses were performed using an LC system 
interfaced to a QTRAP® 4500 mass spectrometer equipped 
with an electrospray Turbo Ion source operated in the 
positive ion mode. A C18 RRHD column (100 mm × 2.1 mm, 
1.8 µm) protected by a C18 pre-column was used for the 
separation of the target analytes. Elution solvents were water/ 
formic acid 5mM (solvent A) and acetonitrile/methanol 
80:20 plus 5 mM formic acid (solvent B). After an initial 
isocratic elution at 95% A for 0.5 min a linear gradient 
elution followed, before isocratic elution at 55% B and the 
total run time was 5.5 min. 
 Extraction recoveries together with limit of detection 
(LOD) and limit of quantification (LOQ) values suggested a 
specific and sensitive method. 
 The method was applied to 77 real cases which had been 
previously tested for traditional drugs of abuse; 23 authentic 
hair samples collected from MDMA and ketamine users 
(group A) and 54 authentic samples from driver’s license 
regranting cases which had been found negative, when tested 
for common drugs of abuse (group B). Substances of 2 C-x 
series were not detected in any of the considered samples. 
The authors attributed the negative results either to possible 
delayed diffusion of these recent drugs among the Italian 
population or to the fact that these psychedelic phenethylamines 
are active at very low doses, reducing the detectable 
concentrations in hair, especially in the cases of sporadic 
intake. Thus, they stressed the need for further improvement 
of the sensitivity of the method to disclose possible presence 
of NBOMes at trace concentrations in hair, after active 
intake. 
2.1.2. Other Phenethylamines 
 A total of five studies have been conducted for the 
determination of phenethylamines other than 2 C-x series in 
hair. A first group of authors developed a LC–ESI-MS/MS 
assay for the simultaneous analysis of NPS and traditional 
drugs in hair [25]. From the phenethylamine group PMA and 
4-MTA, were determined. To 50 mg washed and finely cut 
hair samples internal standards (ISs) and phosphate buffer at 
pH 5.0 were added and incubated for 18 h at 45 °C. Vortex 
and centrifugation was followed by a solid phase extraction 
(SPE) with MCX®, Oasis®, Waters cartridges. 
 The separation and detection of the analytes was 
achieved by using LC coupled with an atmospheric pressure 
Ionization (API) 2000 MS/MS System equipped with a 
Turbo Ion Spray ionization source optimized in positive 
ionization mode. Chromatographic separation was carried 
out on an Atlantis® T3 column (150 x 2.1-mm I.D., 3 µm) 
and the MP consisted of (A) 2 mM ammonium formate, pH 
3.0, and (B) acetonitrile/A (90:10, v/ v). Gradient elution 
was used and the total run time was 24 min. 
 LOD values of 10 and 20 pg/mg were achieved for PMA 
and 4-MTA, respectively and LOQ of 0.050 ng/mg for both 
substances. 
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 This method was routinely applied to hair samples and 
two forensic cases were described. However no NPS were 
detected in examined samples, but traditional drugs of abuse. 
 A second group of authors, already mentioned for 2 C-x 
series, using the same UHPLC–MS/MS assay, determined 
PMA, PMMA, 4-FA, 5-MAPB, 6-APB and butylone after 
methanolic hair extraction achieving high recoveries ≥94% 
and LOD and LOQ values from 1.3-17 pg/mg and 2.6-35 
pg/mg, respectively [27]. In one case, out of 77 investigated 
cases, hair was tested positive for 4-FA at the concentration 
of 55 pg/mg, together with other NPS and MDMA. 
 Strano-Rossi and co-workers described an UHPLC–
MS/MS method, based on two different runs (i.e. different 
matrix extractions and chromatographic separations), for the 
determination of more than 50 NPS, belonging to different 
chemical classes in hair [24]. 4-MA, 4-MTA, 4-FA and 
butylone were among the investigated analytes. An aliquot 
of approximately 30 mg washed and cut hair was extracted 
by overnight incubation under sonication at 45oC using 0.1% 
formic acid in the presence of ISs. Analyses were performed 
using an UHPLC instrument coupled to triple quadrupole 
mass spectrometer. The column was a superficially porous 
Kinetex C18 column (2.6 µm, 100 × 2.1 mm) and the MPs 
used were: (A) 5 mM ammonium formate containing 0.1% 
formic acid and (B) methanol/acetonitrile 1:1 with 0.1% of 
formic acid. Two different MP gradients were employed; 
one for cannabinoids and one for cathinones and other 
stimulants because of too different chemical structures. 
Electrospray ionization (ESI) Jet-Stream was operated in 
positive mode. The method was proved to be reproducible 
and sensitive and applied to 50 samples coming from 
forensic cases (postmortem toxicological analyses, driving 
license regranting and workplace drug testing). None of the 
analytes under investigation were detected. 
 Hair samples from 325 routine cases, which originally 
tested positive for amphetamines or MDMA were reanalysed 
by Rust et al. in a study to evaluate the diffusion of NPS 
among typical MDMA and/or amphetamine users [28]. Hair 
fragments were decontaminated by a three-step washing 
procedure and extracted using a two-step extraction procedure 
(16 h, ultrasonication in methanol and 3 h, ultrasonication in 
acidified methanol). The analytes were separated using a 
liquid chromatography and detected by a linear ion trap 
quadrupole mass spectrometer operated in the ESI mode. 
Gradient elution was carried out on a Phenomenex Kinetex 
PFP column (2.6 mm, 50/2). The mobile phase consisted of 
5mM ammonium formate buffer adjusted to pH 3.5 with 
formic acid (eluent A) and methanol containing 5mM 
ammonium formate (eluent B). 
 Among the compounds tested were 4-FA and butylone. 
4-FA was identified in 4% of the cases under investigation. 
 Lendoiro et al. developed and fully validated a LC-
MS/MS assay for the determination of 4-FMA among other 
psychoactive substances in hair [26]. Hair specimens (30 
mg) were incubated in acidic methanol (0.1% HCl) and 
extracted by a mixed-mode SPE. Chromatographic separation 
was performed using an Atlantis T3 (3 µm; 2.1x50 mm) 
analytical column, and 2 mM ammonium formate pH 3 and 
acetonitrile as mobile phase. Precision and accuracy values 
within the acceptable range were obtained. Accuracy was 
expressed as the percentage of the nominal concentration, 
and was required to be within 85-115% of the target 
concentration. The validated method was applied to 16 hair 
samples, which were all found negative for 4-FMA. 
2.2. Analytical Methods for the Determination of 
Piperazines in Hair 
 Piperazine-like compounds fall within the category of 
NPS and have already been found in the illegal drug market 
as substitute or constituent of MDMA in suspected MDMA 
seized pills. Piperazine-like compounds may act as stimulants 
and can produce euphoria, whereas some compounds of this 
class (e.g. TFMPP and mCPP) have small hallucinogenic 
potential [33]. 
 Six studies described methods for the detection and 
quantification of piperazines in hair. In their previously 
mentioned multi-analyte LC–ESI-MS/MS assay after SPE, 
Imbert et al. included the determination of mCPP [25]. 
Using their UHPLC–MS/MS method after extraction in 
0.1% formic acid Strano-Rossi et al. determined mCPP and 
benzylpiperazine [24]. Piperazines were not detected in none 
of the latter studies, when applied to real cases. 
 Another research group developed and validated a 
sensitive and simple gas chromatography-mass spectrometry 
(GC-MS) method for the identification and quantification  
of mCPP, TFMPP and MeOPP in hair [33]. A 20 mg 
decontaminated and cut hair sample was cleaned up by mixed 
mode solid-phase extraction after short hair incubation (40 
min) with 1M NaOH at 50oC. Extracts were derivatized with 
N-methyl-N-(trimethylsilyl) trifluoroacetamide with 5% 
trimethylchlorosilane and p-tolylpiperazine (pTP) was used 
as IS. A gas chromatograph equipped with a mass selective 
detector and capillary column (30m×0.25mm I.D., 0.25µm 
film thickness) with 5% phenylmethylsiloxane was used for 
the analysis. 
 The method was applied to both post- and ante-mortem 
(subjects under antidepressant treatment with trazodone for 
the detection of mCPP and individuals undergoing psychiatric 
evaluation) real samples. Although results from the authentic 
hair samples were not presented, authors stated that the 
method could find application in forensic toxicology routine 
analysis. 
 Lendoiro et al. determined mCPP and TFMPP using the 
previously reported LC-MS/MS method which employed 
SPE for analytes extraction [26]. When the method was 
applied to 16 authentic hair specimens, ten positive results 
for mCPP were obtained in the range of 341.7-4000 pg/mg; 
however, in all cases trazodone identification (2085.3–4000 
pg/mg) indicated a licit origin of mCPP as a metabolite of 
trazodone. 
 In their UHPLC–MS/MS multi-analyte assay Salomone 
et al. included hair testing of mCPP [27] and Rust and co-
workers determined mCPP, benzylpiperazine and TFMPP 
using their method which employs 2 step extraction and LC-
MS/MS analysis [28]. After the application of the latter 
method to 325 real cases, mCPP was found positive in 34 
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cases and TFMPP in one case. Five mCPP cases were also 
positive for trazodone. 
2.3. Analytical Methods for the Determination of 
Synthetic Cathinones in Hair 
 Synthetic cathinones are chemical analogs of cathinone, a 
psychoactive monoamine alkaloid present in the shrub of 
Khat plant (Catha edulis). Cathinone derivatives are the β-
keto (βk) analogues of the corresponding phenethylamine. 
Psychoactive stimulant substances belonging to the class of 
synthetic cathinones have been linked to varying degrees of 
agitation, confusional states, hyper arousal, and various types 
of psychotic behavior, up to and including a syndrome 
indistinguishable from excited delirium syndrome [43]. 
Moreover, synthetic cathinones can produce neurological and 
cardiovascular side-effects consistent with sympathomimetic 
toxicity [44]. 
 Nine studies investigated the presence of synthetic 
cathinones in hair of possible consumers. 
 Namera et al. [35] were the first in detecting MDPV in 
hair sample coming from a deceased subject, whose cardiac 
blood contained 1200 ng/ml MDPV and 200 ng/ml α-PBP. 
Although the death was attributed to MDPV poisoning, hair 
test was performed to investigate chronic use. Hair samples 
were extensively washed with both aqueous and organic 
solutions and cut into 10 mm segments up to ten cm. Each 
segment was then treated with alkaline solution, in the 
presence of IS, and then extracted, evaporated and re-
dissolved in methanol aqueous solution, before injected into 
the LC-MS system. Separation was achieved using a phenyl-
hexyl column (150 mm x 2.1 mm i.d.,3 µm) with a mobile 
phase of methanol/ammonium formate solution (10 mM 
ammonia aqueous solution containing 0.1 % formic acid, pH 
3.3) (35:65, v/v). 
 Segments analysed were positive for MDPV and α-PVP, 
with the highest MDPV concentration being 22 ng/10-mm 
hair, confirming previous intake of MDPV and α-PVP. 
Traces of α-PBP were also detected in the first segment (the 
one closet to the scalp). However, the concentrations 
provided per 10 mm and not per mg of hair did not allow any 
comparison with results from other studies. The authors 
reported that their findings suggest chronic MDPV and α-
PVP use for at least 5 months, since both drugs were 
detected in the first 5 segments of 10 mm each. 
 In their multi-analyte method, Salomone et al. [27] 
determined α-PVP, buphedrone, amfepramone, 4-MEC, 
ethcathinone, mephedrone, methylone, pentedrone and 
MDPV after an extraction in methanol and determination in 
UHPLC–MS/MS. When they applied the method to 23 cases 
coming from MDMA and ketamine users, 3 were found 
positive to the latter drugs. In detail, in one case 4-MEC and 
mephedrone were detected at the concentration of 330 and 
50 pg/mg, respectively; in another case, mephedrone was 
found at 59 pg/mg. In the last case of this group, α-PVP was 
detected together with methylone, MDPV and other NPS at 
the concentration of 1040 pg/mg, <LOQ and 120 pg/mg, 
respectively. In one out of 54 authentic samples from 
driver’s license regranting which had been found negative, 
when tested for common drugs of abuse, methylone was 
quantified in a sample at 28 pg/mg. 
 In their above mentioned UHPLC–MS/MS method for 
NPS hair testing, Strano-Rossi et al. [24] included 3,4-DMMC, 
4-MEC, ethcathinone, ethylone, mephedrone, methedrone, 
methylone, naphyrone, pentedrone, pentylone, 4-FMC and 
MDPV after hair treatment with formic acid 0.1%. 
 Three samples out of 50, coming from forensic cases, 
were positive for cathinones: MDPV at a concentration of 50 
pg/mg in one case, 4-MEC at a concentration below LOQ in 
another and at 26 pg/mg in the last one. 
 In their LC-MS/MS method for the evaluation of the 
prevalence of NPS by hair testing, Rust et al. included the 
investigation of ethylone, mephedrone, methcathinone, 
methylone and MDPV in hair, after two step sample extraction 
with methanol and acidic methanol [28]. Methylone was 
detected in one out of 325 samples tested and mephedrone in 
3% of the cases. 
 Pubic hair drug testing for the detection of 3-MMC and 
its metabolites, by means of liquid chromatography–high 
resolution/ high accuracy Orbitrap mass spectrometry (LC-
HRMS), was used to document their potential intake by a 
drug dealer [7]. Pubic hair samples were decontaminated, 
pulverized using a ball mill, extracted in the presence of IS 
by overnight incubation with methanol:trifluoroacetic acid 
9:1 and analysed. 
 The LC-HRMS system was equipped with a TFS Hypersil 
Gold PFP analytical column (2.1 x 100 mm, 1.9 µm particle 
size) and coupled to a TFS single-stage Exactive high energy 
collisional dissociation (HCD) MS system, interfaced with a 
TFS heated electrospray ionization HESI-II Ion Max source. 
MP A was water with 0.05% formic acid and 10 mM 
ammonium formate and MP B was acetonitrile with 0.05% 
formic acid. 
 Pubic hair specimen was positive for 3-methylmeth- 
cathinone (3-MMC) which was quantified at 25.8 ng/mg.  
3-methylephedrine and 3-methylnorephedrine, metabolites of 
3-MMC, were also detected in the same sample, suggesting 
3-MMC intake by the drug dealer. 
 In their above reported multi-analyte LC-MS/MS assay, 
Lendoiro et al. [26] included hair testing of mephedrone, 
methedrone, methylone, 4-FMC and MDPV, after SPE 
sample treatment. However, none of those substances was 
detected in real cases tested. 
 After developing and validating a method for the 
determination of mephedrone in hair by GC-MS, Martin et 
al. reported the first series of mephedrone positive findings 
in hair samples [45]. Hair samples were decontaminated and 
incubated overnight in Soerensen buffer pH 7.0 in the 
presence of IS. Liquid-liquid extraction (LLE) was performed 
after alkalinisation of the incubation medium. The dry extract 
was derivatized, evaporated and reconstituted in ethyl acetate. 
Gas chromatographic separation was achieved with a 5-MS 
capillary column and detection by single ion monitoring in 
electron impact mode. 
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 Thirteen out of 67 hair tested samples, were found 
positive for mephedrone with concentrations ranging from 
0.2 to 313.2 ng/mg with a mean concentration of 26.8 ng/mg, 
showing enough method sensitivity to demonstrate both 
occasional and regular mephedrone intake. 
 Shah et al. were the first authors in developing and 
validating an UHPLC-MS/MS method for the quantification 
of not only mephedrone but also its two metabolites, 4-
methylnorephedrine and 4-methylephedrine in hair [30]. Hair 
samples were enzymatically digested and extracted using 
LLE technique. The UHPLC-MS/MS system was operated 
in selective reaction monitoring (SRM) mode. The method 
was then applied to 154 real samples, 5 of which were 
confirmed as positive just for mephedrone (only one 
quantified at the concentration of 21.11 pg/mg). 
 Pichini et al. presented for the first time a case of a 
neonatal withdrawal syndrome in a baby born to a woman 
who was a chronic consumer of 4-methylethcathinone [19]. 
4-MEC was identified and quantified by LC-MS/MS in 
neonatal meconium and in 4 subsequent 3 cm segments of 
maternal hair accounting for maternal consumption during 
the whole pregnancy (4.3, 4.0, 4.0 and 3.9 ng/mg hair starting 
from most proximal segment) demonstrating that maternal 
hair testing could provide useful information on chronic 
gestational use of 4-MEC in relation to neonatal outcome. 
2.4. Analytical Methods for the Determination of 
Synthetic Cannabinoids in Hair 
 Synthetic cannabinoids are among the most commonly 
used NPS, which all act as agonists at the cannabinoid CB1 
receptor. They are usually purchased as cannabis-like drugs, 
marketed as herbal blends and perceived as risk-free by 
inexperienced users. Synthetic cannabinoids may lead to 
severe health consequences, including tachycardia, anxiety, 
violent behavior, hallucinations and psychosis [46, 47]. 
2.4.1. Benzoylindoles 
 In their above reported method for hair NPS testing 
Strano-Rossi et al. [24] included a number of synthetic 
cannabinoids. The extraction process for these compounds 
differs from the previously mentioned one, due to the 
different chemical properties of cannabinoids. Briefly, thirty 
mg decontaminated and cut hair were incubated overnight 
under sonication at 45oC with MeOH in the presence of JWH 
210-d9 as IS. Of benzoylindole group, AM2233, AM694, 
RCS-4 and WIN 48,098 were determined in hair. Out of 50 
real cases, AM694 (30 pg/mg) was detected in one sample 
together with other synthetic cannabinoids of other chemical 
classes. Also Montenarh et al., included in their LC-MS/MS 
hair screening method cannabinoids of benzoyindole family: 
AM694 and RCS4, after extraction with diethyl ether-ethyl 
acetate mixture [29]. The method was applied to 13 hair 
samples but results were not given. Salomone et al. expanded 
a previously developed UHPLC-MS/MS method for the 
detection of 23 synthetic cannabinoids in hair specimens in 
order to include new emerging compounds [32]. Three out of 
the 23 cannabinnoids investigated come from the benzoyindole 
group i.e. AM694, RCS4 and WIN 48,098. 
 The newly developed and validated method was used for 
the evaluation of the consumption of the latter drugs over a 
large period of examination, and the diffusion of 
cannabimimetics among different populations of drug users. 
Prior to analysis hair specimens were undergone digestion 
with NaOH and extracted with a mixture of n-hexane/ 
ethylacetate. A reversed phase C18 column (100 mm × 2.1 
mm, 1.7 µm), protected by a C18 VanGuard pre-column, 
was used for the separation of the analytes. Mobile phases 
were water/formic acid 20 mM plus ammonium formate 2 
mM (solvent A) and acetonitrile/formic acid 20 mM (solvent 
B). Regarding instrumental analysis, ion source operated in 
the positive ion mode. The validated method was applied to 
344 hair samples previously analysed for common drugs or 
alcohol; no cannabinoids of benzoylindole family detected. 
 Another sensitive, rapid and simple assay using LC-
MS/MS was developed and fully validated by Hutter and co-
workers for the determination of 22 synthetic cannabinoids 
in hair, 4 of them belonging to the benzoyindoles class: AM 
694, RCS-4, RCS-4 ortho isomer and WIN 48,098 [34]. 
Extraction was achieved by 3-h ultrasonification of 50 mg 
hair in ethanol. Separation of the target analytes was carried 
out on a Luna Phenyl Hexyl column (50 mm × 2 mm, 5 µm) 
with an equivalent guard column (4 mm ×2 mm). Elution 
solvent A consisted of water with 0.2% formic acid and 2.0 
mmol/L ammonium formate and solvent B was methanol. 
The method was proved to be precise, accurate, specific, 
linear and selective but no positive samples were found to 
these cannabinoids in examined cases. 
 A rapid screening method employing liquid chromato- 
graphy-quadrupole-time of flight mass spectrometry (LC-
QTOF MS) was developed by Gottardo et al. for the 
detection of synthetic cannabinoids in hair [8]. From 
benzoylindoles, AM 694 was included in the assay. Hundred 
mg hair were cut and incubated overnight under strong basic 
conditions and were twice extracted by LLE. Organic layers 
from the two extractions were put together, evaporated, 
reconstituted in methanol and analysed. The separation was 
achieved on a Zorbax Eclipse XDB (2.1 x 150 mm, 5 µm) 
with gradient elution. 0.1% formic acid was the MP A and 
methanol was the MP B. The developed method was applied 
to 435 authentic hair samples from subjects to whom the 
driving license had been suspended/ withdrawn for ‘‘driving 
under the influence’’ of psychoactive drugs in order to 
evaluate the diffusion of these new compounds in the 
population, but none resulted positive for AM 694. 
2.4.2. Naphthoylindoles 
 In their expanded UHPLC-MS/MS method for 
cannabinoids hair testing, Salomone et al. included the 
following cannabinoids of the naphthoylindole group: AM-
1220, AM-2201, JWH-007, JWH-015, JWH-018, JWH-019, 
JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, WIN 
55,212-2 JWH-398 [32]. Fifteen real samples out of 344 
tested were found positive for at least one synthetic 
cannabinoid of naphthoylindoles. 
 JWH-073 was detected in 11 samples out of 344 tested 
generally at low concentrations (mean 7.69 ± 14.4 pg/mg, 
median 1.9 pg/mg, range 1.6–50.5 pg/mg) followed by JWH-
122 in 8 samples (mean concentration: 544 ± 968 pg/mg, 
median 28.4 pg/mg, range 7.4–2800 pg/mg). JWH-081 
(range 8-194 pg/mg), JWH-018 (range 3.1-17.3 pg/mg), 
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JWH-210 (range 2.3-5.1 pg/mg), JWH-019 (range 3.8-4.1 
pg/mg), and AM-1220 (1.3 pg/mg) were also detected. 
 AM-2201, JWH-007, JWH-015, JWH-018, JWH-019, 
JWH-073, JWH-081, JWH-098, JWH-122, JWH-200 and 
JWH-398 were present in the multi-analyte UHPLC–MS/MS 
method of Strano-Rossi et al. [24]. Three samples, out of 50 
real cases, resulted positive for more than one synthetic 
cannabinoid. In the first case, JWH-073 (below LOQ), JWH-
018 (20 pg/mg), JWH-081 (470 pg/mg) together with 
AM694 were determined. In another case, JWH-073 was 
detected at 2.1 ng/mg and JWH-018 at 90 pg/mg and finally 
in the third case JWH-073, JWH-018 and JWH-081 were all 
detected (<LOQ). 
 Likewise AM2201, JWH-015, JWH-018, JWH-073, 
JWH-122, JWH-200 and JWH-210 were included in the LC-
MS/MS screening method of Montenarh et al., after extraction 
of the pulverized hair with diethyl ether-ethyl acetate mixture 
[29], but no positive result in real cases was obtained. 
 Hutter et al. determined 12 compounds of the 
naphthoylindole group: AM2201, JWH-007, JWH-015, 
JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-
200, JWH-210, WIN 55,212-2 and JWH-398, using the 
previously described LC-MS/MS cannabinoid-based method 
which employed ethanol extraction [34]. In 9 examined 
samples, the proximal hair segment tested positive for JWH-
081 in 7 cases (range: 5.1-78 pg/mg), JWH-073 in 7 cases 
(range of 0.7-21 pg/mg), JWH-210 in 3 cases (range 0.5-5.2 
pg/mg) and JWH-018 in two cases at 5.1 and 5.7 pg/mg, 
respectively. In the first segment, concentrations of up to 78 
pg/mg JWH-081 were present. In segmental analysis, the 
levels of most substances increased from the first (closest to 
the scalp) to the third segment. The highest concentration 
was about 1100 pg/mg JWH-081. The findings of segmental 
hair tests in chronic users suggest side-stream smoke 
condensation as a major route of incorporation of the drugs 
in head. 
 Kim et al. developed and validated a LC/MS-MS method 
for the determination of 5 naphthoylindole-based synthetic 
cannabinoids and their metabolites in human and rat hair 
[37]. The following substances were invastigated: AM2201, 
AM-2201 N-4-OH M, AM-2201 N-6-OHindole M, JWH-
122, JWH-122 N-5-OH, MAM-2201, MAM-2201 N-COOH 
M, MAM-2201 N-4-OH M. All analytes were extracted  
with methanol from washed and cut hair samples and the 
extracts were injected into LC–MS/MS with electrospray ion 
source in the positive ionization mode. AM-2201 and its 
monohydroxylated metabolites were detected in rat model 
and then the ratios of metabolite-to-parent drug were 
calculated to be used as criteria on external contamination. 
The effect of pigmentation on the distribution of AM-
2201and its monohydroxylated metabolites in hair was also 
evaluated using animal model, showing no significant 
differences. Wide variation in concentrations of the 5 parent 
drugs and their metabolites was noticed when analyzing real 
hair samples coming from 9 cases of suspected of synthetic 
cannabinoids use; a range of 0.4–59.2 pg/mg for JWH-018, 
0.1–0.8 pg/mg for JWH-073, 1.7–739.0 pg/mg for AM-2201, 
0.1–402.0 pg/mg for JWH-122, 0.2–276.0 pg/mg for MAM-
2201, 0.2–1.1 pg/mg for JWH-018N-COOH, 0.3–37.2 pg/mg 
for JWH-018 N-5-OH, 0.3 pg/mg for JWH-073 N-COOH, 
0.4 pg/mg for AM-2201N-4-OH, 0.2–3.1 pg/mg for AM-
2201 N-6-OHindole and 0.1–3.5 pg/mg for JWH-122 N-5-
OH. 
 Three cannabinoids of the naphthoylindole category: 
JWH-018, JWH-073 and JWH-200 were investigated by 
Salomone et al. by hair digestion with NaOH and LLE 
extraction followed by analytes separation and detection 
with an UHPLC/MS-MS operating in the selected reaction 
monitoring mode [31]. A Zorbax XDB-C18 column 30 mm 
x 2.1 mm, 1.8 µm, protected by a C18 guard column, was 
used for the separation of the analytes. The elution solvents 
were water/formic acid 5mM (solvent A) and acetonitrile 
(solvent B). The method was successfully applied to the 
analysis of authentic samples collected from proven cannabis 
consumers. Fourteen out of 179 hair samples, two of which 
were pubic hair, collected by frequent users of THC-
containing products, were found positive to at least one 
synthetic cannabinoid. JWH-018 was detected in 8 head hair 
samples and 1 pubic hair at the range of 0.6-70.5 pg/mg and 
1.5 pg/mg, respectively. JWH-073 was determined in 7 head 
hair and 1 pubic hair specimen at the range of 0.5-413.3 
pg/mg and 1.7 pg/mg, respectively. THC was always present 
in the samples tested positive for synthetic cannabinoids. 
 Also Kim et al. set up and validated an assay for the 
detection of JWH-018, JWH-073, and their metabolites in 
hair using UHPLC-MS-MS [36]. The analytes were extracted 
from hair with methanol; the extract was then filtered and 
analyzed by UHPLC–MS–MS with an electrospray ion 
source in positive-ionization mode. The validated method 
was then used for the investigation of the distribution of 
synthetic cannabinoids metabolites in hair; moreover the 
effect of hair pigmentation, by use of an animal model was 
also evaluated. The method was applied to authentic hair 
samples obtained by 18 individuals suspected of synthetic 
cannabinoids intake. The animal study showed that JWH-
073 N-COOH M was the major metabolite of JWH-073 in 
rat hair, and hair pigmentation did not significantly affect the 
incorporation of JWH-073 and its metabolites into hair. 
JWH-018 (range: <LOQ-1700pg/mg), JWH-018 N-5-OH M 
(range: <LOQ-85 pg/mg), and JWH-073 (range: <LOQ-55 
pg/mg) were detected in 18 real hair specimens. 
 In their LC-QTOF MS, Gottardo et al. method included 
the following substances: JWH-018, JWH-073, JWH-081, 
JWH-122, JWH-200 and JWH-210, after hair treatment 
under strong basic conditions and double LLE [8]. The latter 
substances were detected in 8 cases out of 435; two of which 
were found positive for more than one compound of 
naphthoylindoles. 
 JWH-018, JWH-073, JWH-081 and JWH-122 were 
detected in 3 (range 0.010 - 0.011 ng/mg), 2 (0.017 and 
0.750 ng/mg), 4 (range 0.016 – 1.280 ng/mg) and 1 (0.125 
ng/mg) cases, respectively. 
2.4.3. Phenylacetylindoles 
 Montenarh et al. investigated also the following 
substances of the phenylacetylindole group using their LC-
MS/MS screening method after extraction of the pulverized 
hair with diethyl ether-ethyl acetate mixture: JWH-203, and 
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JWH-250 [29]. The method was applied to 13 hair samples; 
however results were not provided. Likewise, Salomone et 
al. using their expanded method developed for the 
determination of cannabinoids in hair analysed for JWH-203, 
JWH-250, JWH-251 and RCS-8 [32]. JWH-250 found 
positive in 6 cases (range: 4.8-83.4 pg/mg) out of 15 cases 
tested positive for synthetic cannabinoids and a total of 334 
samples. 
 Hutter et al. analysed for the same substances as 
Salomone et al. using the previously described LC-MS/MS 
cannabinoid-based method which employs ethanol extraction 
[31, 32, 34]. JWH-250 was detected in 8 real samples 
together with other synthetic cannabinoids at the range of 
0.5-24 pg/mg. 
 Strano-Rossi et al. analysed the following substances of 
phenylacetylindole group using the previously mentioned 
UHPLC–MS/MS multi-analyte method after MeOH 
extraction: JWH-250, JWH-251, JWH-302 and RCS-8 [24], 
whereas In their first cannabinoid-based method in hair 
Salomone et al. and using their LC-QTOF MS method 
Gottardo et al. [8] analysed for JWH-250 [31]. JWH-250 
detected in 8 authentic samples (range: 1.5-729.4 pg/mg) and 
in one case at the concentration of 12 pg/mg by Salomone et 
al. and Gottardo et al., respectively. 
2.4.4. Naphthoylpyrroles 
 Two group of authors included naphthoylpyrroles in their 
assays: Strano-Rossi et al. determinates JWH-030, JWH-147 
and JWH-307 [24], whereas Salomone et al. included only 
the JWH-307 in their previously described LC-MS/MS 
method [32]. None of these compounds detected when the 
latter methods were applied to real cases. 
2.4.5. Other Cannabinoids 
 Using both their cannabinoid-based assays Salomone et 
al. [31, 32] investigated the presence of HU-210 in hair, 
whereas using their expanded LC-MS/MS method they 
checked for hair JWH-020 [32]. Applying the previously 
described LC-MS/MS cannabinoid-based method which 
employs ethanol hair extraction, Hutter et al. [34] determined 
methanandamide (AM-356) and JWH-020. None of these 
substances identified when the latter methods were applied 
to authentic specimens. 
 Park et al. [38] described a quantitative analytical method 
for the determination of XLR-11 and its metabolites in hair 
using LC-MS/MS, since the latter drug has been widely 
abused in South Korea recently. The authors stated that the 
detection of the metabolites in hair samples could exclude 
external contamination and prove actual consumption. The 
hair specimens were washed, cut and extracted in methanol. 
LC–MS/MS with electrospray ion source operating in 
positive-ionization mode was used for the analysis. The 
chromatographic separation was performed in a Zorbax 
Eclipse plus C18 (RRHD 2.1×100mm, 1.8µm). The validation 
results suggest that the method was accurate, selective, linear 
and precise. 
 It was then applied to 14 hair samples taken from 
individuals suspected of XLR-11 use. XLR-11 and 4 out of 
the 5 metabolites tested were detected (mainly UR-144 N-5-
hydroxy metabolite and UR-144 N-pentanoic acid). Wide 
variation was noticed regarding the concentrations revealed 
from the analysis of the latter samples both for XLR-11 and 
its metabolites, with the concentration of the parent drug 
ranging from 0.8 to 5350.0 pg/mg. The concentration of 
XLR-11 as a parent drug was much higher compared to the 
metabolites. In one case only the parent drug was identified 
at low concentration leading the authors to suggest either 
external contamination of the hair sample or intake of 
impurity of other synthetic cannabinoids. UR-144 N-4- 
hydroxypentyl metabolite was not detected in authentic 
samples. 
 Strano-Rossi et al. investigated the following substances: 
CB-13, JWH-016 and JWH-201 using the previously 
reported UHPLC–MS/MS multi-analyte method after MeOH 
extraction [24]. None of these analytes were detected in the 
authentic samples. 
 Franz et al. [39] performed LC- MS/MS hair analysis of 
a real sample collected from a patient with a known history 
of abuse of synthetic cannabinoids. 5F-PB-22 and 
ABCHMINACA as well as their main metabolites 5F-PB-22 
3-carboxyindole, PB-22 5-OH-pentyl, and AB-CHMINACA 
valine were identified in all segments. The authors evaluated 
the stability of the parent drugs in the hair matrix and under 
thermal stress, revealing that the three metabolites are also 
formed in externally contaminated hair after their storage at 
different conditions. LLOQs of 1 and 2.5 pg/mg were 
achieved for 5F-PB-22 and AB-CHMINACA, respectively. 
 Moreover, 5F-PB-22 3-carboxyindole and AB-
CHMINACA valine were detected as degradation products 
in smoke condensate. Thus the authors concluded that 
caution must be taken when interpreting the ‘metabolite’ 
findings of compounds consisting of chemically labile amide/ 
ester bonds or 5-fluoro-pentyl side chains, taking into 
consideration the different mechanisms of formation and 
incorporation into hair. 
 A method for the detection of indole-derived cannabinoids 
(naphthoylindoles, phenylacetylindoles and benzoylindoles) 
in hair, oral-fluid, blood and urine has been developed using 
LC-MS/MS based on the use of precursor ion scan as the 
acquisition mode [40]. The authors proposed an alternative 
approach that focuses on the detection of specific molecular 
moieties, recurrent within the same pharmacological class of 
substances. The method was developed to recognize one or 
more common “structural markers”, which correspond to 
mass spectral fragments coming from the specific moiety  
of the molecular structure that is common to the 
aminoalkylindole analogues and that is essential for their 
pharmacological categorization. Therefore, the assay is also 
suitable for identifying unknown compounds, given that they 
contain the targeted portion of the molecular structure. 
2.5. Analytical Methods for the Determination of other 
NPS in Hair 
 Salomone et al. in their multi-analyte method included 
also MXE, 4-MeO-PCP and diphenidine after an extraction 
in methanol and determination by UHPLC–MS/MS [27]. 
Analyzing hair samples from MDMA or ketamine users, 
MXE was detected in three samples with a range of 
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concentration between 7.7 and 28 pg/mg and diphenidine in 
one sample at the concentration of 4400 pg/mg. 
3. DISCUSSION AND CONCLUSION 
 The huge amount of methods detailed in the table and the 
results on real cases presented in the previous Sections 
suggest that methods for the determination of NPS in hair, 
are in continuous development together with some existing 
analytical methods for hair testing expanded to include as 
many NPS as possible due to an increasing demand to disclose 
their eventual presence in hair of users. Some studies have 
been carried out for the evaluation of the prevalence and 
diffusion of NPS. Reanalysis of previously tested hair 
samples for common drugs of abuse revealed some positive 
results for these new psychoactive compounds suggesting on 
the one hand their underestimated prevalence in users of 
recreational drugs and on the other a hand the need for NPS 
screenings to be routinely employed both in forensic and 
clinical toxicology. The presented results strongly support 
the use of hair analysis to monitor the diffusion of new 
psychoactive drugs in the users’ community. 
 Advances in mass spectrometry technology enabled the 
improvement of sensitivity so that these novel substances, 
whose used doses are in the majority of cases unknown can 
be detected in low concentrations, i.e. pg per mg hair 
whereas traditional drugs of abuse are usually in the range of 
ng per mg keratin matrix. 
 Hyphenated mass spectrometric techniques are and will 
be indispensable tools in clinical and forensic toxicology and 
doping control. Whereas GC/MS in the EI mode plays a 
major role particularly in comprehensive screening procedures 
because a very large collection of reference spectra is 
available and the cost of the instrument is not excessive, 
LC/MS with different mass analyzer types is becoming more 
and more a standard technique for automated target screening 
procedures and particularly for high –throughput quantification. 
In fact LC/MS has shown to be an ideal supplement, especially 
for detection of more polar, unstable or low-dose drugs [48-
53]. This latter evidence is supported by our results; although 
very few GC-MS methods have been described for the 
determination of NPS in hair, the vast majority of studies 
conducted on this regard use LC/MS-MS or UHPLC–
MS/MS. Moreover, LC-QTOF MS and LC-HRMS have also 
been used with LODs at decimal picograms achieved. 
 With both types of analytes separation (GC or LC), the 
run time reported for the examined methods was quite short 
since the high throughput of analysis in pharmacotoxicological 
laboratories is now a principal crucial task in forensic toxicology 
and clinical pharmacotoxicology. Matrix decontamination is 
considered to be one of the main limitations in hair testing. 
The Society of Hair Testing (SoHT) guidelines state that 
external contamination must be taken into account when 
interpreting the findings and laboratories should evaluate the 
effectiveness of their wash procedures. In the here presented 
methods, great heterogeneity has been noted regarding 
decontamination step with some studies following extensive 
washing procedures and others none at all. Nonetheless, 
some authors used both aqueous and organic solvents, as 
proposed by Society of Hair Drug Testing for traditional 
drugs of abuse [54]. 
 A pitfall, common with the published procedures for 
common psychotropic drugs is the difficulty in evaluating 
the real performance of the extraction procedure due to the 
lack of certified reference hair specimens with known drug 
content; various extraction methods have been suggested to 
isolate NPS from hair such as methanol extraction or 
hydrolysis in alkaline solution followed by LLE or SPE 
depending on the chemical properties of the analytes. 
 Among the positive samples obtained from the analysis 
of authentic cases, the measured levels for most of the drugs 
were interestingly in the range of picograms of drug per 
milligrams of hair, either suggesting sporadic exposure to 
these substances or low rate of incorporation into the keratin 
matrix. However, only limited literature data concerning the 
detection of these new drugs in hair samples are currently 
available, making the interpretation of NPS concentrations in 
hair samples still ambiguous [27]. 
 Moreover, the need for established cut-off values to 
discriminate between chronic consumption and occasional 
use (or external contamination) is underlined since 
epidemiological studies based on hair testing on NPS are still 
few and different ranges of concentration for different types 
of consumption patterns are far from being decided. 
 The results on hair samples compliment a series of 
investigation already presented in other papers applied in 
different biological matrices which can create a clinical set 
for the demonstration of consumption, which can be then 
associated with the clinical outcome with an intoxication or a 
fatality. 
LIST OF ABBREVIATIONS 
2 C-B = 2,5-dimethoxy-4-bromophenethyl- 
amine  
2 C-D = 2,5-dimethoxy-4-methylphene- 
thylamine 
2 C-E = 2,5-dimethoxy-4-ethylphenethyl- 
amine 
2 C-I = 2,5-dimethoxy-4-iodophenethyl- 
amine  
2 C-P = 2,5-dimethoxy-4-(n)-propylphene- 
thylamine 
2 C-T = 2-(2,5-dimethoxy-4-(methylthio) 
phenyl)ethanamine or 4-methylthio-
2,5-DMPEA  
25B-NBOMe = 2-(4-bromo-2,5-dimethoxyphenyl)-
N-[(2-methoxyphenyl)methyl] 
ethanamine 
25C-NBOMe = 2-(4-chloro-2,5-dimethoxyphenyl)-
N-[(2-methoxyphenyl)methyl] 
ethanamine 
25H-NBOMe = 2-(2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine  
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25I-NBOMe = 2-(4-iodo-2,5-dimethoxyphenyl)-
N-[(2-methoxyphenyl)methyl] 
ethanamine 
3,4-DMMC = 3,4-Dimethylmethcathinone  
3-MMC = 3-Methylmethcathinone 
4-FA = 4-Fluoroamphetamine  
4-FMA = 4-Fluoromethamphetamine  
4-FMC = 4-fluoromethcathinone or flephedrone  
4-MA = 4-Methylamphetamine  
4-MEC = 4-Methylethcathinone  
4-MeO-PCP = 4-Methoxyphencyclidine 
4-MTA = 4-Methylthioamphetamine  
5F-PB-22 = 1-pentyfluoro-1H-indole-3-
carboxylic acid 8-quinolinyl ester 
5-MAPB = 1-(Benzofuran-5-yl)-N-
methylpropan-2-amine 
6-APB = 6-(2-aminopropyl)benzofuran 
AB-CHMINACA = N-[(1S)-1-(Aminocarbonyl)-2-
methylpropyl]-1-(cyclohexylmethyl)-
1H-indazole-3-carboxamide 
AM-1220 = (R)-(1-((1-methylpiperidin-2-yl) 
methyl)-1H-indol-3-yl)(naphthalen-
1-yl)methanone 
AM2201 = 1-(5-fluoropentyl)-3-(1-naphthoyl) 
indole 
AM2233 = 1-[(N-methylpiperidin-2-yl) 
methyl]-3-(2-iodobenzoyl)indole 
AM694 = 1-(5-fluoropentyl)-3-(2-iodobenzoyl) 
indole 
CB-13 = naphthalen-1-yl-(4-pentyloxyna- 
phthalen-1-yl)methanone 
HU-210 = (6aR,10aR)- 9-(Hydroxymethyl)- 
6,6-dimethyl- 3-(2-methyloctan-2-
yl)- 6a,7,10,10a-tetrahydrobenzo [c] 
chromen- 1-ol 
JWH-007 = 1-pentyl-2-methyl-3-(1-naphthoyl) 
indole 
JWH-015 = (2-Methyl-1-propyl-1H-indol-3-
yl)-1-naphthalenylmethanone 
JWH-016 = (1-butyl-2-methyl-1H-indol-3-yl)-
1-naphthalenyl-methanone 
JWH-018 = 1-pentyl-3-(1-naphthoyl)indole 
JWH-019 = 1-hexyl-3-(naphthalen-1-oyl)indole 
JWH-020 = (1-heptyl-1H-indol-3-yl)-1-
naphthalenyl-methanone 
JWH-030 = naphthalen-1-yl-(1-pentylpyrrol- 
3-yl)methanone 
JWH-073 = naphthalen-1-yl-(1-butylindol-3-
yl)methanone 
JWH-081 = 4-methoxynaphthalen- 1-yl- (1-
pentylindol- 3-yl)methanone 
JWH-098 = 4-methoxynaphthalen-1-yl-(1-
pentyl-2-methylindol-3-yl) 
methanone 
JWH-122 = (4-methyl-1-naphthyl)-(1-
pentylindol-3-yl)methanone 
JWH-147 = (1-hexyl-5-phenyl-1H-pyrrol-3-
yl)-1-naphthalenyl-methanone 
JWH-200 = (1-(2-morpholin-4-ylethyl)indol-
3-yl)-naphthalen-1-ylmethanone 
JWH-201 = 2-(4-methoxyphenyl)-1-(1-phentyl-
1H-indol-3-yl)-ethanone 
JWH-203 = 1-pentyl-3-(2-chlorophenylacetyl) 
indole 
JWH-210 = 4-ethylnaphthalen-1-yl-(1-
pentylindol-3-yl)methanone 
JWH-250 = 1-pentyl-3-(2-methoxyphenylacetyl) 
indole 
JWH-251 = 1-pentyl-3-(2-methylphenylacetyl) 
indole 
JWH-302 = 1-pentyl-3-(3-methoxyphenylacetyl) 
indole 
JWH-307 = (5-(2-fluorophenyl)-1-pentylpyrrol-
3-yl)-naphthalen-1-ylmethanone 
JWH-398 = 1-pentyl-3-(4-chloro-1-naphthoyl) 
indole 
MAM-2201 = (1-(5-fluoropentyl)-1H-indol-3-
yl)(4-methyl-1-naphthalenyl)-
methanone 
mCPP = meta-Chlorophenylpiperazine  
MDPV = Methylenedioxypyrovalerone  
MeOPP = para-Methoxyphenylpiperazine  
MXE = Methoxetamine  
PMA = para-Methoxyamphetamine  
PMMA = para-Methoxy-N-methylamphetamine 
RCS-4 = 1-pentyl-3-(4-methoxybenzoyl) 
indole 
RCS-8 = 1-(2-cyclohexylethyl)-3-(2-metho- 
xyphenylacetyl)indole 
TFMPP = 3-Trifluoromethylphenylpiperazine 
UR-144 = (1-pentylindol-3-yl)-(2,2,3,3-
tetramethylcyclopropyl)methanone 
WIN 48,098 = Pravadoline or (4-methoxyphenyl)-
[2-methyl-1-(2-morpholin-4-ylethyl) 
indol-3-yl]methanone 
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WIN 55,212-2 = (R)-(+)-[2,3-Dihydro-5-methyl- 3-
(4-morpholinylmethyl)pyrrolo 
[1,2,3-de]-1,4-benzoxazin-6-yl]- 
1-napthalenylmethanone 
XLR-11 = (1-(5-fluoropentyl)-1H-indol-3-yl) 
(2,2,3,3-tetramethylcyclopropyl) 
methanone 
α-PBP  = α-Pyrrolidinobutiophenone 
α-PVP = α-Pyrrolidinopentiophenone 
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